Theratechnologies Inc T.TH

New corporate presentation

[Lee430]

New Speptember corporate presentation is up.

https://www.theratech.com/investors/news-events/presentations

[SPCEO1]

Based on a quick review (really quick) I did not see anything significantly new in this presentation.

[qwerty22]

Does anybody have the previous version? I feel like the toxicity/efficacy pages 21/22 have more detail but I might be wrong.  

[SPCEO1]

Those slides were in the presentation issued on 8/10/22. That was the first time they showed up in a corporate presentation. The reason for releasing the new presentation now is TH is likely meeting with investment firms prior to the Cantor conference. They will not be presenting this presentation at the Cantor conference itself as that is more of a thematic discussion on a topic that pertains to

[SPCEO1]

The new corproate presentaton also suggests there will be no new info coning out prior to the Cantor conference. If there were new info coming, they may have waited until it came out to put out a new corporate presentation. So, 10/13 is the next  most likely time for an update on TH-1902. And if they update us on the progress of the trial then, it more likely to be a "soft" update

[jfm1330]

When I saw the stock price this morning, I went to see if there was a press release, and what caught my eye was the "provide business update" part. It was not there a year ago on the press release to announce the CC for Q3. It also was not there for Q1 of this year, but the "business update" part was there for Q2 PR, and they indeed had somenthing to update us about. Also

[qwerty22]

I'll be more specific. On the toxicity table, in the noted toxicity column, I don't remember having details of the 300mg toxicities. I know I've been moaning about the lack of transparency around the 300mg dose toxicities. I know there was no detail in the original data release. I guess I'd forgotten they'd added it to the presentation update if it was there in the Aug version.

[palinc2000]

Slide 23 below suggests that there are still a lot to learn on the Sort 1 Technology...Promising maybe but saying  that its on the cusp of becoming something big is an overstatement atm... SORT1+ TechnologyTM: Future Opportunities Explore conjugation with a variety of anti-cancer agents (cytotoxics, TKIs etc) and potential synergistic new partnerships (proprietary molecules). Explore

[muslix1]

CIBC big buyer today... on small volume

[FredTheVoice]

MUSLIX, do you think we will see 14$ again ??? You know what......just check another pharma.....BLU on the TMX....... That company is not that different from TH- Are in phase II for a med....... Lets see what tomorrow brings..... Good luck and take care, FTV

[muslix1]

yes on a buyout for sure.. but i dont know when but, enjoy today my freind

[scarlet1967]

2790bafc-6443-4aed-a90c-1cb2957c3330 2790bafc-6443-4aed-a90c-1cb2957c3330   https://www.theratech.com/static-files/8d86c08a-229e-4e9c-8ad2-ef353b8a4fbf   “Part 1 of the study is currently open to recruitment only in the USA.  Once MTD, RD and safety are established, part 2 (expansion) will open in sites in the USA, UK, and Europe.”   https://www.theratech.com

[palinc2000]

How can you tell the trading today in the US was from retail?  I really thought that thru IR and other sources some investors have finally realized that the market cap did not even represent the value of existing legacy drug sales So the current SP does not take into account any increase in legacy drugs sales nor any potential positive development in the pipeline. No downside and only

[scarlet1967]

I can't find anything explaining the sudden increase interest but it is not what JFM suggested as many of their previous PRs do mention business updates. I am not even sure the trading was solely from the retail but they added 50 or more watchers on Stocktwits which are usually retail. I do agree the current undervaluation is due lack of belief in the prospect of THTX's commercial and R

[scarlet1967]

... locating our targets and sending people to the sites presenting the company, signage, cold calls etc all to create exposure now less than a year since the start we have expanded our fleet by over 300 percent the business was cash flow neutral in the first 3 months and now projected to have almost near 7 figur revenues and 6 figures net profit. Yes we did a lot of DD before the start and the

[PWIB123]

I think that's pretty obvious.  The huge increase in followers on Stocktwits and the increase in messages should be enough to prove that today's trading activity was entirely retail investor driven.  Especially, since that came off the heels of the release of that mention from ZipTrader.  People are posting questions like "How much can this pop if approved?" 

[PWIB123]

Instituional investors can't do much until the stock reaches $5.  The best thing that could happen to the stock in this moment is retail drives the price to $5+ through new and exciting news flow indicating short-term tradeable milestones that they hang onto right up to the release of efficacy where institutional investors then pour in.  Let's go!